ArticleEchocardiography (Mount Kisco, N.Y.)2026
Utility of Three-Dimensional Echocardiography for Ventricular Assessment in Congenital Heart Disease: A Comparative Retrospective Study.
Article in Echocardiography (Mount Kisco, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAccurate quantification of ventricular volumes and function is critical for managing congenital heart disease (CHD) and guiding surgical and interventional decisions. Although cardiac magnetic resonance imaging (CMR) and cardiac catheterization (CA) are gold standards, their use is limited by availability, invasiveness, and patient tolerance. Three-dimensional echocardiography (3DE) offers a non-invasive alternative; however, validation across modalities in heterogeneous CHD populations is limited. The aim of this study was to evaluate the clinical utility of 3DE in patients with CHD by comparison with against measurements obtained by CMR and CA.
methodsWe retrospectively analyzed patients with CHD undergoing 3DE, CMR, and CA. Ventricular end-diastolic volume (EDV), end-systolic volume (ESV), ejection fraction (EF), and cardiac index (CI) were measured and compared across the three modalities. 3DE data were analyzed using Philips QLAB. Correlation coefficients, regression equations, and Bland-Altman analyses were used to assess agreement across modalities.
resultsThirty-six patients were included between 2024 and 2025. Strong correlations were observed between 3DE and CMR (LVEDV r = 0.94, RVEDV r = 0.93) as well as 3DE and CA (LVEDV r = 0.86, RVEDV r = 0.89). 3DE systematically underestimated volumes (3DE < CMR < CA). EF showed excellent correlation across modalities, whereas CI exhibited greater variability. Bland-Altman analysis confirmed a systematic bias that remained within clinically acceptable limits for population-level assessment, although individual-based variability should be considered.
conclusions3DE provides reliable volumetric and functional assessment in patients with CHD, with strong correlation with CMR and CA despite systematic underestimation of absolute values. 3DE is a practical noninvasive modality for serial follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.